Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth

British Journal of Pharmacology

Volumn 121, Issue 7, 1997, Pages 1350-1354

  Grohe C ^a,d   Kahlert, S ^a   Lobbert K ^a   Van Eickels, M ^a   Stimpel, M ^b   Vetter, H ^a   Neyses, L ^c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cardiac fibroblasts; egr 1; Moexiprilat; Oestrogens

Indexed keywords

ANGIOTENSIN; BROXURIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; MOEXIPRILAT;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HEART; IMMEDIATE EARLY GENE; IMMUNOBLOTTING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT;

EID: 0030751773     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701263     Document Type: Article

References (11)

1. BRILLA, C.G., MATSUBARA, L. & WEBER, K.T. (1996). Advanced hypertensive heart disease in spontaneously hypertensive rats. Hypertension, 28, 269-275.
2. CICATIELLO, L., SICA, V., BRESCIANI, F. & WEISZ, A. (1993). Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor, 3, 17-30.
3. GROHÉ, C., BRIESEMEISTER, G., STIMPEL, M., KARAS, R.H., VETTER, H. & NEYSES, L. (1994). Functional estrogen receptors in myocardial and myogenic cells. Circulation, 90, I-538.
4. GROHÉ, C., KAHLERT, S., LÖBBERT, K., MEYER, R., LINZ, K., KARAS, R. & VETTER, H. (1996). Modulation of hypertensive heart disease by estrogen. Steroids, 61, 201-204.
5. 1 receptor activation. J. Clin. Endocrinol. Metab., 80, 1233-1237.
6. MIGLIACCO, A., DIDOMENICO, M., CASTORIA, G., DE FALCO, A., BONTEMPO, P., NOLA, E. & AURICCHIO, F. (1996). Tyrosine kinase/p21ras/MAP-kinase pathway activation by estrogen-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
7. SCHATZKIN, A., CUPPLES, L.C. HEEREN, T., MORELOCK, S. & KANNEL, W.B. (1984). Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am. J. Epidemiol., 120, 888-899.
8. SCHORB, W., BOOZ, G.W., DOSTAL, D.E., CONRAD, K.M., CHANG, K.C. & BAKER K.M. (1993). Angiotensin II is mitogenic in neonatal caardiac fibroblasts. Circ. res., 72, 1245-1254.
9. SIMPSON, P. & SAVION, S. (1982). Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Circ Res, 50, 101-116.
10. STAUSS, H.M., ZHU, Y.C., REDLICH, T., ADAMIAK, D., MOTT, A., KREGEL, K.C. & UNGER, T. (1994). Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J. Cardiovasc. Res., 3, 255 262.
11. WHITE, W.B., FOX, A.A. & STIMPEL, M. (1994). Long-term efficacy and safety of moexipril in the treatment of hypertension. J. Human Hypertens., 8, 917-921.